Newron Pharmaceuticals SpA (NWRN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.119x

Based on the latest financial reports, Newron Pharmaceuticals SpA (NWRN) has a cash flow conversion efficiency ratio of 0.119x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-1.33 Million ≈ $-1.68 Million USD) by net assets (CHF-11.13 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Newron Pharmaceuticals SpA market cap and net worth for the company's overall valuation and market capitalisation.

Newron Pharmaceuticals SpA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Newron Pharmaceuticals SpA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Newron Pharmaceuticals SpA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Newron Pharmaceuticals SpA ranked by their cash flow conversion efficiency. Explore NWRN operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Aviat Networks Inc NASDAQ:AVNW	0.012x
Cafe24 Corp KQ:042000	0.058x
Grupa Azoty Zaklady Chemiczne Police SA WAR:PCE	0.539x
Pioneer High Income Closed Fund NYSE:PHT	0.046x
Zura Bio Limited Class A Ordinary Shares NASDAQ:ZURA	-0.130x
E. W. Scripps Co Class A NASDAQ:SSP	0.135x
Monogram Orthopaedics Inc. Common Stock NASDAQ:MGRM	-0.267x
Stille AB ST:STIL	0.015x

Annual Cash Flow Conversion Efficiency for Newron Pharmaceuticals SpA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Newron Pharmaceuticals SpA from 2005 to 2025. View Newron Pharmaceuticals SpA (NWRN) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-11.13 Million ≈ $-14.07 Million	CHF32.56 Million ≈ $41.17 Million	-2.926x	+75.78%
2024-12-31	CHF1.46 Million ≈ $1.84 Million	CHF-17.61 Million ≈ $-22.27 Million	-12.081x	-3663.28%
2023-12-31	CHF-29.91 Million ≈ $-37.81 Million	CHF-10.14 Million ≈ $-12.82 Million	0.339x	-57.12%
2022-12-31	CHF-14.03 Million ≈ $-17.74 Million	CHF-11.09 Million ≈ $-14.02 Million	0.791x	+121.46%
2021-12-31	CHF3.11 Million ≈ $3.93 Million	CHF-11.45 Million ≈ $-14.47 Million	-3.684x	-307.54%
2020-12-31	CHF17.25 Million ≈ $21.80 Million	CHF-15.59 Million ≈ $-19.71 Million	-0.904x	-51.35%
2019-12-31	CHF36.80 Million ≈ $46.52 Million	CHF-21.98 Million ≈ $-27.78 Million	-0.597x	-105.27%
2018-12-31	CHF54.84 Million ≈ $69.33 Million	CHF-15.95 Million ≈ $-20.17 Million	-0.291x	-134.45%
2017-12-31	CHF67.72 Million ≈ $85.62 Million	CHF-8.40 Million ≈ $-10.62 Million	-0.124x	+68.48%
2016-12-31	CHF49.75 Million ≈ $62.89 Million	CHF-19.58 Million ≈ $-24.76 Million	-0.394x	-13.58%
2015-12-31	CHF37.11 Million ≈ $46.92 Million	CHF-12.86 Million ≈ $-16.26 Million	-0.347x	-1.43%
2014-12-31	CHF29.26 Million ≈ $36.99 Million	CHF-10.00 Million ≈ $-12.64 Million	-0.342x	+32.56%
2013-12-31	CHF21.09 Million ≈ $26.66 Million	CHF-10.69 Million ≈ $-13.51 Million	-0.507x	-340.15%
2012-12-31	CHF27.61 Million ≈ $34.90 Million	CHF5.83 Million ≈ $7.36 Million	0.211x	+128.11%
2011-12-31	CHF6.58 Million ≈ $8.33 Million	CHF-4.94 Million ≈ $-6.25 Million	-0.750x	+52.17%
2010-12-31	CHF12.19 Million ≈ $15.41 Million	CHF-19.13 Million ≈ $-24.18 Million	-1.569x	-99.27%
2009-12-31	CHF29.28 Million ≈ $37.02 Million	CHF-23.06 Million ≈ $-29.15 Million	-0.787x	-80.96%
2008-12-31	CHF45.81 Million ≈ $57.92 Million	CHF-19.93 Million ≈ $-25.20 Million	-0.435x	-80.11%
2007-12-31	CHF57.40 Million ≈ $72.57 Million	CHF-13.87 Million ≈ $-17.53 Million	-0.242x	-70.22%
2006-12-31	CHF67.86 Million ≈ $85.79 Million	CHF-9.63 Million ≈ $-12.17 Million	-0.142x	+83.14%
2005-12-31	CHF17.02 Million ≈ $21.52 Million	CHF-14.33 Million ≈ $-18.12 Million	-0.842x	--

About Newron Pharmaceuticals SpA

SW:NWRN Switzerland Biotechnology

Market Cap

$293.03 Million

CHF231.78 Million CHF

Market Cap Rank

#15860 Global

#169 in Switzerland

Share Price

CHF11.14

Change (1 day)

+2.58%

52-Week Range

CHF10.28 - CHF30.40

All Time High

CHF30.40